Summary.-Ninety-seven fresh explants of human tumours have been cultured in vitro in an attempt to predict their sensitivity to subsequent cytotoxic chemotherapy. Only 3/26 solid ovarian tumours were cultured successfully although 12 of the 23 which failed to grow proved later to have benign histology. Of 10 solid tumours from other sites, only 2/4 renal tumours and one melanoma were successfully grown and tested in vitro. A higher success rate was achieved in culturing carcinoma cells of ovarian (10/22) and breast (10/22) origin from ascitic and pleural fluids. Using increase in cell number after 7 days' growth in vitro as the biological end-point, concentrations of cytotoxic drugs which are achievable in patients produced significant effects on some tumour explants. Detailed studies of serial subcultures in vitro from an ovarian tumour showed that large changes in chemosensitivity occur within about 2 passages in vitro, so that sensitivity testing can only be carried out using fresh explants or their first subcultures if any possible correlation between in vitro cytotoxicity and in situ response is to be studied. Clinical effectiveness and in vitro chemosensitivity are compared for a limited number of patients with ovarian and breast carcinomata for whom follow-up information was available; no useful correlation was found.
Tms PAPER presents the results of the first 25 months' efforts in this laboratory to predict their subsequent response in vivo to cytotoxic chemotherapy by studies of fresh explants of human tumours in vitro. Obtaining tumour samples in no case required that the patients underwent any procedures other than those normally needed for their diagnosis and treatment.
As early as 1957, correlations were claimed between the responses of human tumours in tissue culture and their subsequent response in situ to cytotoxic chemotherapy (Wright et al., 1957) . A number of different biochemical and cytological end-points have been chosen for such studies and extremely high levels of agreement have been claimed between the results obtained in vitro and those in the patient (e.g. Sky-Peck, 1964; Limburg, 1969) . Other authors have been more cautious (e.g. Wolberg, 1971) and recent detailed studies of a spontaneous murine mammary carcinoma have shown little or no agreement between in vitro and in vivo activity of several cytotoxic drugs (Balconi et al., 1973) . The most comprehensive studies of chemosensitivity testing in vitro which have been carried out in the U.K. have been those of Dendy and his collaborators at Cambridge. This group has used as its biological end-point the short-term incorporation into DNA of radioactively labelled precursors after exposure to the cytotoxic agent (Mitchell et al., 1971 tumour cells. When this drug was tested, an additional control flask was prepared containing an equivalent amount of DMSO (0-02 ml/ml growth medium) but no chlorambucil. After addition of the drug to be tested, the flasks were incubated for 7 days at 370C without agitation or change of medium, and the floating and attached cells then counted as described. The choice of a 7-day incubation period resulted from the observation that rapid growth usually ceased by about 5 days after initiation of the cultures, whilst a decrease in total cell number due to exhaustion of the growth medium rarely occurred before 12 days; the 7-day period represented very nearly the maximum growth and was a time at which only small errors might be introduced by up to 8 h variations in total incubation time due to counting the cultures at different times in the working day.
RESULTS
The sites of origin of the tumours studied and the rates of success in obtaining primary cultures and chemosensitivity testing are summarized in Table II . overall increase in number during a 7-day period whereas ascitic cells from carcinoma of the breast showed 3-to-13-fold overall growth in the same period. On serial subculture, however, the rate of growth of ascitic tumour cells from one ovarian carcinoma increased rapidly to reach a stable plateau by their second trypsinization (Fig. 1) , which differed little from the total growth seen in ascitic cells from breast carcinomata at their initial explantation. The results obtainecd with serially propagated cultures from patient E.W. (Fig. 1-3 The results presented here, however, offer little assurance that chemosensitivity testing in vitro of freshly explanted human tumours will allow dramatic improvement in the prognosis of patients with disseminated malignant disease whose only therapeutic hope at present is cytotoxic chemotherapy.
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